TDOC going to $6.66I wouldn't touch it until it gets to that level... but even then, you'll need to closely evaluate it. Here's a simple chart. Don't catch the knife. catch the bottom.
TDOC trade ideas
TDOC: Rotation to small caps could launch this!Teladoc is primed to hit a massive run. Volume has been accumulating for the past 2 years and has been picking up recently. There are a few areas of resistance in the way but with insiders buying and volume pilling up on top of the recent rotation to small caps, there is a high change of short squeeze up to at least 45.
All eyes on this ER, which is probably going to be the trigger or failure of this theory.
TDOC: $33.0 | Bid at Sub $20 to $5.0 some big player is shorting this issue in accordance to earnings and forward cashflows..
this Covid Sweetheart is getting a reset..
re org change CEO and board then re pack for the next 4 years
Teladoc partners with Brightline to expand into paediatricTeladoc Health Inc., a leader in the US telemedicine market, has announced a strategic partnership with Brightline, a digital platform specialising in mental health care for children, adolescents, and their families. This partnership marks Teladoc's entry into a new and promising healthcare market segment, focusing on paediatric mental health – a critical area of growing need.
Through this collaboration, Teladoc Health will integrate Brightline's expertise in paediatric psychology and psychiatry into its telemedicine service, offering access to specialised care for a sensitive and complex patient group. This move expands Teladoc's service range and positions it at the forefront of addressing the rising mental health challenges among younger populations.
Technical analysis of Teladoc Health Inc. (NYSE: TDOC)
Let us explore the potential trading opportunities based on the current technical setup of Teladoc's stock:
Timeframe : Daily (D1)
Current trend : the stock is showing signs of the beginning of an uptrend
Resistance level : 10.15 USD
Support level : 9.25 USD
Potential downtrend target : if the stock enters a downtrend, the downside target could be around 8.70 USD
Short-term target : if the uptrend continues and the stock breaches the resistance at 10.15 USD, a short-term target could be set at 11.85 USD
Medium-term target : with sustained positive momentum, the stock price might rise to 13.40 USD
Investors should closely monitor Teladoc Health's performance, particularly in light of this new partnership with Brightline. Integrating specialised paediatric mental health services could significantly enhance Teladoc's market position and potentially increase stock value as the company taps into this underserved sector.
—
Ideas and other content presented on this page should not be considered as guidance for trading or an investment advice. RoboMarkets bears no responsibility for trading results based on trading opinions described in these analytical reviews.
The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law L. 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments.
Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65.68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
TDOC may bring a lot of profit??1) RSI's 2 moving averages have crossed already each other. Purple one went above green one and it is buy sign. Also RSI's Resistance Line was broken.
2) MACD shows that: Upper trend is gaining power because green bars are lengthing and it is dark green not light green.
3) Momentum Resistance Line did not work. Momentum increased a lot but it is still less than 0. It shows that: Down trend is losing its power but it may still decrease because it is less than 0. When it goes above 0 line it will be another buy sign. On the other hand, i drew support line of Momentum. If support line is not broken, it will be more than 0 and trend will go upper.
4) CCI's 0 line can be used for strategy and it is very important for some securities which lost its value more than %90. This is experience. If CCI cuts above 0 line, it will be buy sign.
5) This is not certain but may work why not. Target Price = (Highest price level + Lowest price level)/2
Target Price = 161$ ????
ALL COMMENTS DO NOT INCLUDE INVESTING ADVICE!!!
TDOC is back? looks like a buyBig picture, TDOC is on support levels and they just got a brand new CEO. Earnings on the 23rd... I'll post some follow up charts zoomed in.
Double BottomTDOC is testing all time low, at the same time testing the bottom trendline of the descending wedge. Good R/R to at least the upper trendline around 15. This price target is based on the earnings date. Breakout of wedge to the upside is the light blue line.
6/13/24 - $tdoc - interesting sub $10, but want <$86/13/24 :: VROCKSTAR :: NYSE:TDOC
revisiting this one b/c i had flagged to myself to "not care" until we hit $10. well here we are on 6/13, at $10.
so what gives, do we start buying, get interested or just hand sit.
my bias is to hand sit still. the tape is dramatically different than when i made this comment in early april - and this company as well as others that are "unprofitable, not opex leverage inducing, not growing like a weed"... the market says i don't want.
we gotta respect mr. market. those r the rules fam.
so what's this thing objectively worth given meager (LSD - low single digit) sales growth?
given no opex leverage? given they seem to be a marginal share loser in what would seem like a promising category of telemedicine that defn got a pull-forward from covid but is still giving some back...
trends.google.com
i'd posit one way to look at this is to use my R&D rule of thumb. at 25% discount rate at $350 mm a year invested then double that - it's $2.8 bn - a 25-30% bump from the enterprise value today.
but the mkt won't pay for that logic - bc the results suggest the discount rate on R&D is either unknowable or much much higher. so $2.8 bn is the ceiling valuation. and 25-30% upside isn't amazing (we just did 15% a day in NASDAQ:AVGO results - so that's the bar guys, good charts, good results, rips).
at $8 we basically get this thing at a discount to gross profit, which buys us some time to turn that opex inflection, see a few quarters and probably not go too much lower and it's in play (take out potential).
conclusion - for those who know the company well, and if ops r looking decent - it's an obvious buy here - very shorted. but for me - that covers everything, i just don't see the allure of jumping into a difficult turn around, chart, financials. i need a heady discount.
so i'm setting a flag at $8 and we update this thinking if/as we get there. and if it just rips from here, we let it go. congratulate those putting their nuts on the line. but i won't be one, not yet and not in this tape
V
Teladoc: Bearish on American Mental Health? Bullish on TDOCTDOC provides video therapy and telehealth services. They blew up their stock price buy wasting 12Bn on a useless acquisition because the executives got a bit too excited and horny to spend their cash during the COVID bubble. Nonetheless, revenues are linearly growing, and American mental health is in rapid, precipitous, unstoppable decline.
There is some concern that LLM's or AI will take away the market share for therapists and human therapy, but I think that actually, personally, AI interactions on a daily basis will make humans more willing to pay for the human interaction provided by Teladoc therapists, even if it is contrived.
Nonetheless, I'm a technical analyst first and foremost, there is a clear stop, we had the final rage sell already, and there is a clear mean reversion target on the recovery rally. I think it would be wise to have a TP1 at $80, but I am ultimately targeting 155 as laid out in the chart.
This is a $3.5Bn company so it's not as though this piece is a cheap pump.
Teladoc's Bumpy Ride: From Telemedicine Champion to Flop
Teladoc Health Inc. (NYSE: NYSE:TDOC ) once stood as a beacon of hope in the realm of healthcare innovation, poised to revolutionize the way people access medical services through telemedicine. However, what was once a soaring success story has now become a cautionary tale of overambition and strategic missteps, as evidenced by the company's staggering decline in stock price and ongoing struggles to meet investor expectations.
The Rise and Fall:
In the midst of the COVID-19 pandemic, Teladoc's ( NYSE:TDOC ) stock skyrocketed to unprecedented heights, reaching a peak of $308.28 per share. Yet, this euphoria was short-lived, as the company's value plummeted to less than $20, marking one of the most dramatic collapses witnessed in recent years. The catalyst for this downfall? A series of strategic blunders, most notably, the ill-fated $18 billion acquisition of Livongo Health.
The Livongo Debacle:
Teladoc's ( NYSE:TDOC ) acquisition of Livongo Health was meant to be a game-changer, a strategic move that would cement its position as a dominant force in the healthcare industry. However, what ensued was a costly mistake that sent shockwaves through the market. The deal, which initially seemed promising, quickly soured, resulting in a staggering $13 billion noncash impairment charge and a significant erosion of shareholder value.
Financial Turbulence:
The repercussions of Teladoc's ( NYSE:TDOC ) missteps were felt acutely in its financial performance. Despite once being hailed as a growth story, the company's revenue growth has stagnated, with fourth-quarter revenues rising by a meager 4% year-over-year to $661 million, falling short of analyst estimates. Additionally, Teladoc's ( NYSE:TDOC ) guidance for future revenue growth has been tepid at best, with projections suggesting a paltry 2.5% increase.
Challenges Ahead:
Teladoc's ( NYSE:TDOC ) woes extend beyond its financial struggles. The company faces mounting challenges in a post-pandemic landscape, with the allure of virtual healthcare waning as traditional clinics and hospitals reopen their doors. Moreover, attempts to capitalize on upselling opportunities have faltered, leaving Teladoc grappling with a shrinking market and dwindling investor confidence.
Market Outlook:
As Teladoc ( NYSE:TDOC ) braces for further turbulence, analysts predict a grim future for the once-promising stock. With expectations of downward revisions to earnings estimates looming on the horizon, the company's shares are poised to experience further declines, potentially plummeting to a low of $15 per share, representing a staggering 30% drop from recent levels.
TDOCCovid cases not hitting peak yet... long multi year downtrend. Getting some upside lately.
Decent r/r .. risking a bit over a dollar to see if it gets back to test that $30 mark
TeladocFounded in 2002, Teladoc predates the widespread adoption of telemedicine by almost a decade, making them a true pioneer in the field. In 2015, Teladoc became the first pure-play telemedicine company to go public, marking a significant milestone for the industry.
Impact and Growth:
1. Increased Access to Care: Teladoc has made healthcare more accessible for millions, particularly those in rural areas, those with limited mobility, and those without insurance.
2. COVID-19 Boom: The pandemic fueled a surge in telemedicine usage, with Teladoc experiencing a 70% increase in visits in 2020 alone.
3. Global Expansion: Teladoc operates in over 175 countries and 45 languages, providing care to a diverse patient population.
Beyond Video Calls:
1. AI-powered Services: Teladoc is not just about video calls. They offer AI-powered chatbots for symptom assessment, mental health therapy through their subsidiary BetterHelp, and chronic disease management programs.
2. Corporate Partnerships: Many employers offer Teladoc as a benefit to their employees, further driving growth and accessibility.
3. Tech Integration: Teladoc is constantly innovating, partnering with wearable device companies, and integrating data from these devices into their platform.
Organizational Customers:
1. Employers: Over 50% of Fortune 500 companies, including giants like Walmart, Apple, and IBM, offer Teladoc as a healthcare benefit to their employees. This provides convenient and affordable access to doctors for millions of workers.
2. Health Plans: Major health insurance companies like Aetna, Cigna, and UnitedHealthcare partner with Teladoc to offer telemedicine services to their members. This helps health plans control costs and improve member satisfaction.
3. Hospitals and Health Systems: Many hospitals and health systems use Teladoc to extend their reach and provide virtual care services to patients in remote areas or after discharge. This helps reduce hospital readmission rates and improve patient outcomes.
Individual Customers:
1. Direct-to-Consumer: Individuals can subscribe to Teladoc's services directly, paying a monthly fee or per-visit charge. This is a convenient option for people who don't have health insurance or who want to avoid the hassle of traditional doctor visits.
2. Mental Health: Teladoc's subsidiary, BetterHelp, provides online therapy and counseling services to individuals. This is a valuable resource for people who may not have access to in-person mental health care.
As of 2023, Teladoc had over 56 million paid members in the United States alone. The company serves more than 450 hospitals and health systems worldwide. Teladoc's virtual care platform has been used for over 15 million visits.
Overall, Teladoc is playing a major role in making healthcare more accessible and affordable for people around the world. The company's diverse customer base is a testament to the wide range of needs that telemedicine can address.
We will be adding Teladoc to our portfolio.
TDOC Bottoming Tail W/ Sign Of Trend ReversalHere is a view of the TDOC chart on the daily time frame.
What we see here in is a clear downtrend in the stock TDOC.
If you take a look at yesterday's price action it was higher than normal volume with an initial flush down.
After the initial sell off TDOC had a great reversal and went positive on the day putting in what is known as a bottoming tail.
The bottoming tail with high volume now indicates that the downtrend has bottomed out and an uptrend should be beginning.
If the bottoming tail gets taken out then the bottoming tail would be negated and the down trend will most likely continue.
What do you see in this chart?
TDOC health ... FALLEN angel long 18.75 set up , trying to form a base , against all technical rules im trying to catch a falling knife as some time being a contrarian pays off , solely concentrating on the risk / reward element , base building going on last few sessions , long 18.75 add 18 stoploss cls below 16 , adding more on break out above 20 and trailing stop with every move to save position
Testing...I bought this stock a few weeks back waiting for a break out. Finally happened and now it is pulling back to test the broken upper vertex. I'm not adding, I already have a good position here. But It is a good time to jump in. The company already had its earnings call and was good. The $22 zone is a strong support so if for some reason the price is pulled back to that support zone I would add.
Long TDOC -Teledoc HealthThis chart is hilarious lol. Building a long here, 33% in- will add once I see more confluence. Company apparently is making money. Real product, real people. Down horrendously, 95% +. 1-3 month trade. Not advise. Good luck.
Multiple bottom at $23Multiple bottom at $23.
The current wave is slowing down at the same level.
Possible reversal waiting for our Bullish Alert.
TDOC waiting on a long entryIf you have been following me on StockTwits you know that I traded into July Earnings. After a nice pop to $30 to retest the top of its trading range it’s been shorted back towards the bottom of its trading channel.
To be clear NOTHING about this chart is Bullish except for the fact that it has previously bounced in the $21.50-23.00 area. I am not seeing any new options trades of interest, darkpool data or insider trades to support a long entry. Per FinViz the Short Float / Ratio is 16.97% / 5.27.
TDOC next reports earnings on or around 10/25/23. Other potential catalysts could include spinnout, merger, takeover news.
Based on past trading patterns I would expect traders will be looking add long positions in the $22 area with a target at the top of the trading range around $30.
TDOC - Update after a Bullish WeekIve been eyeing TDOC for some time, finally posting a chart on it talking about TA developments that may indicate a potential bottom area earlier this week (Check below for the link to that chart). I was also in the camp of TDOC going lower to the low $20 or high Teens ($18-19).
This weeks move of 30%, closing the weekly candle at 20% gains was a wonderful surprise.
Its important to NOTE, however that the move is NOT SET IN STONE yet -> For WEEKLY Timeframe
We are hitting a MAJOR confluence of RESISTANCES. Though we are ever so peaking our head out atm, next 1-2 weeks will show more evidence with confirmation.
FOr example: Next week CLOSE being a bullish single candle or next couple weeks printing a bullish candlestick pattern sequence.
The other side is that It could very well be a fake out/ SELL OFF and we do come back down to make a final lower low before we really become bullish. But in my opinion, the probability of a fake out maybe less.
We've moved above the 21 week EMA as well, we would need to confirm support above it in the coming weeks but being above 21 EMA indicates bullish activity.
NOTICE the Bollinger bands. Notice how it has narrowed, this could indicate volitility to pick up and we need to see price stay above median line and be near the upper band. We must Observe what happens in the coming weeks.
The Bollinger median line and 21 EMA are converging and can act as strong support zone. If we do come back down in price.
On the DAILY timeframe, we acted as SUPPORT on both the PURPLE major RESISTANCE line from all time highs and RESISTANCE line from July 2022. Just note however i would need more confirmation in the coming days by staying above as support, to be confident we stay at these levels. If we do, next weeks candle stays above and no fakeout occurs.
RSI is breaking out of the Horizontal resistance line that kept RSI range bound since OCT 2021. (indicated by black line)
This tells me, the BULLISH DIVERGENCE is at play. We would want RSI to continue UP, or follow the Green arrowed path drawn. We absolutely do NOT want the Red arrow. Which is a possibility but less probable in my opinion.
STOCH RSI, a momentum indicator shows that we have a bullish momentum cross, showing that there is still gas left in the tank for us to move. Expect it to go above the 80 level.
Conclusion + trade setups:
For stocks that are 80+% off there tops, averaging in always is a nice strategy.
I think under $30 is cheap for TDOC, especially with all these TA challenges being slowly conquered. There is no denying that it is highly probable we go up eventually, as we've reached critical historical support, and have been consolidating around here for awhile. Alot of indicators and other signs are leaning towards a bottom being formed or already formed.
*CHECK OUT A more detailed TDOC chart from earlier this week BELOW*
A swing trade idea could be taking positions using the Daily timeframe, putting stop loss below the PURPLE line. Making sure you manage your risk properly.
I would rely more on the WEEKLY timeframe and a confirmation that we've made it above the resistance, plus weekly candles are more macro and powerful. This would also be for holding/ longer term investing.
THANK YOU! Hope this update helped. If you like the content, please boost and follow. Please do comment with your opinions! Would love a discussion.
DISCLAIMER: I am not a Financial advisor. This is NOT financial advise. This is my opinion and for educational purposes.
$TDOC looks primed for a move up.NYSE:TDOC has been showing positive divergence on both the RSI and MACD over the past year+, and if price can break above the resistance zone where it is now currently consolidating in, a larger move could be in play over the next month or more. Taking August calls.
$TDOC looking ready to runTDOC had a good earnings report and a breakout on the weekly pennant. Orange lines are resistance. If it breaks the top resistance, we can see mid $70s. Overall market trend can hold this back.
TDOC Teladoc Health Options Ahead of EarningsIf you haven`t sold TDOC here:
Then analyzing the options chain and chart patterns of TDOC Teladoc prior to the earnings report this week,
I would consider purchasing the 20usd in the money strike price Calls with
an expiration date of 2024-1-19,
for a premium of approximately $5.90.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Looking forward to read your opinion about it.
